Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/9613
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kalyoncu, U. | - |
dc.contributor.author | Solmaz, D. | - |
dc.contributor.author | Emmungil, H. | - |
dc.contributor.author | Yazici, A. | - |
dc.contributor.author | Kasifoglu, T. | - |
dc.contributor.author | Kimyon, G. | - |
dc.contributor.author | Balkarlı, Ayşe | - |
dc.date.accessioned | 2019-08-16T13:03:26Z | |
dc.date.available | 2019-08-16T13:03:26Z | |
dc.date.issued | 2016 | - |
dc.identifier.issn | 0896-8411 | - |
dc.identifier.uri | https://hdl.handle.net/11499/9613 | - |
dc.identifier.uri | https://doi.org/10.1016/j.jaut.2016.02.010 | - |
dc.description.abstract | Background: Adult-onset Still's disease (AOSD) is a rare condition, and treatment choices are frequently dependent on expert opinions. The objectives of the present study were to assess treatment modalities, disease course, and the factors influencing the outcome of patients with AOSD. Methods: A multicenter study was used to reach sufficient patient numbers. The diagnosis of AOSD was based on the Yamaguchi criteria. The data collected included patient age, gender, age at the time of diagnosis, delay time for the diagnosis, typical AOSD rash, arthralgia, arthritis, myalgia, sore throat, lymphadenopathy, hepatomegaly, splenomegaly, pleuritis, pericarditis, and other rare findings. The laboratory findings of the patients were also recorded. The drugs initiated after the establishment of a diagnosis and the induction of remission with the first treatment was recorded. Disease patterns and related factors were also investigated. A multivariate analysis was performed to assess the factors related to remission. Results: The initial data of 356 patients (210 females; 59%) from 19 centers were evaluated. The median age at onset was 32 (16-88) years, and the median follow-up time was 22 months (0-180). Fever (95.8%), arthralgia (94.9%), typical AOSD rash (66.9%), arthritis (64.6%), sore throat (63.5%), and myalgia (52.8%) were the most frequent clinical features. It was found that 254 of the 306 patients (83.0%) displayed remission with the initial treatment, including corticosteroids plus methotrexate with or without other disease-modifying antirheumatic drugs. The multivariate analysis revealed that the male sex, delayed diagnosis of more than 6 months, failure to achieve remission with initial treatment, and arthritis involving wrist/elbow joints were related to the chronic disease course. Conclusion: Induction of remission with initial treatment was achieved in the majority of AOSD patients. Failure to achieve remission with initial treatment as well as a delayed diagnosis implicated a chronic disease course in AOSD. © 2016 Elsevier Ltd. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Academic Press | en_US |
dc.relation.ispartof | Journal of Autoimmunity | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Adult-onset Still's disease | en_US |
dc.subject | Disease modifying anti-rheumatic drugs | en_US |
dc.subject | Disease pattern | en_US |
dc.subject | Remission | en_US |
dc.subject | corticosteroid | en_US |
dc.subject | disease modifying antirheumatic drug | en_US |
dc.subject | hydroxychloroquine | en_US |
dc.subject | methotrexate | en_US |
dc.subject | antiinflammatory agent | en_US |
dc.subject | biological marker | en_US |
dc.subject | adult | en_US |
dc.subject | adult onset Still disease | en_US |
dc.subject | arthralgia | en_US |
dc.subject | arthritis | en_US |
dc.subject | Article | en_US |
dc.subject | chronic disease | en_US |
dc.subject | clinical feature | en_US |
dc.subject | cohort analysis | en_US |
dc.subject | delayed diagnosis | en_US |
dc.subject | drug megadose | en_US |
dc.subject | female | en_US |
dc.subject | fever | en_US |
dc.subject | follow up | en_US |
dc.subject | hepatomegaly | en_US |
dc.subject | human | en_US |
dc.subject | laboratory test | en_US |
dc.subject | lymphadenopathy | en_US |
dc.subject | major clinical study | en_US |
dc.subject | male | en_US |
dc.subject | medical record review | en_US |
dc.subject | multicenter study | en_US |
dc.subject | myalgia | en_US |
dc.subject | onset age | en_US |
dc.subject | outcome assessment | en_US |
dc.subject | pericarditis | en_US |
dc.subject | pleurisy | en_US |
dc.subject | priority journal | en_US |
dc.subject | rash | en_US |
dc.subject | remission | en_US |
dc.subject | sore throat | en_US |
dc.subject | splenomegaly | en_US |
dc.subject | treatment failure | en_US |
dc.subject | treatment response | en_US |
dc.subject | adolescent | en_US |
dc.subject | aged | en_US |
dc.subject | clinical trial | en_US |
dc.subject | combination drug therapy | en_US |
dc.subject | middle aged | en_US |
dc.subject | phenotype | en_US |
dc.subject | recurrent disease | en_US |
dc.subject | risk factor | en_US |
dc.subject | Still's Disease, Adult-Onset | en_US |
dc.subject | treatment outcome | en_US |
dc.subject | very elderly | en_US |
dc.subject | young adult | en_US |
dc.subject | Adolescent | en_US |
dc.subject | Adult | en_US |
dc.subject | Aged | en_US |
dc.subject | Aged, 80 and over | en_US |
dc.subject | Anti-Inflammatory Agents | en_US |
dc.subject | Biomarkers | en_US |
dc.subject | Delayed Diagnosis | en_US |
dc.subject | Drug Therapy, Combination | en_US |
dc.subject | Female | en_US |
dc.subject | Humans | en_US |
dc.subject | Male | en_US |
dc.subject | Middle Aged | en_US |
dc.subject | Phenotype | en_US |
dc.subject | Recurrence | en_US |
dc.subject | Remission Induction | en_US |
dc.subject | Risk Factors | en_US |
dc.subject | Treatment Outcome | en_US |
dc.subject | Young Adult | en_US |
dc.title | Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: Data from a large multicenter cohort | en_US |
dc.type | Article | en_US |
dc.identifier.volume | 69 | en_US |
dc.identifier.startpage | 59 | |
dc.identifier.startpage | 59 | en_US |
dc.identifier.endpage | 63 | en_US |
dc.identifier.doi | 10.1016/j.jaut.2016.02.010 | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.pmid | 26970681 | en_US |
dc.identifier.scopus | 2-s2.0-84960153857 | en_US |
dc.identifier.wos | WOS:000374919900006 | en_US |
dc.identifier.scopusquality | Q1 | - |
dc.owner | Pamukkale University | - |
item.languageiso639-1 | en | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
item.openairetype | Article | - |
item.grantfulltext | none | - |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
SCOPUSTM
Citations
68
checked on Nov 16, 2024
WEB OF SCIENCETM
Citations
68
checked on Nov 21, 2024
Page view(s)
38
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.